Fatigue, depression, sleep, and activity during chemotherapy: Daily and intraday variation and relationships among symptom changes

Annals of Behavioral Medicine

Volumn 42, Issue 3, 2011, Pages 321-333

  Jim, Heather S L ^a   Small, Brent ^b   Faul, Leigh Anne ^c   Franzen, Jamie ^b   Apte, Sachin ^a   Jacobsen, Paul B ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

Actigraphy; Chemotherapy; Depression; Fatigue; Gynecologic cancer; Sleep

Indexed keywords

ANTINEOPLASTIC AGENT;

ACTIMETRY; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; COHORT ANALYSIS; DAILY LIFE ACTIVITY; DEPRESSION; FATIGUE; FEMALE; FEMALE GENITAL TRACT TUMOR; HUMAN; INSOMNIA; MENTAL STRESS; MIDDLE AGED; PSYCHOLOGICAL ASPECT; SOCIOECONOMICS;

ACTIGRAPHY; ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COHORT STUDIES; DEPRESSION; FATIGUE; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; SLEEP INITIATION AND MAINTENANCE DISORDERS; SOCIOECONOMIC FACTORS; STRESS, PSYCHOLOGICAL;

EID: 84857060937     PISSN: 08836612     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12160-011-9294-9     Document Type: Article

References (48)

1. Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J: Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr. 2004, 32:40-50.
2. Servaes P, Verhagen C, Bleijenberg G: Fatigue in cancer patients during and after treatment: Prevalence, correlates and interventions. European Journal of Cancer. 2002, 38:27-43. (Pubitemid 34031823)
3. Andrykowski MA, Schmidt JE, Salsman JM, Beacham AO, Jacobsen PB: Use of a case definition approach to identify cancerrelated fatigue in women undergoing adjuvant therapy for breast cancer. Journal of Clinical Oncology. 2005, 23:6613-6622. (Pubitemid 46190255)
4. Medeiros M, Oshima CT, Forones NM: Depression and anxiety in colorectal cancer patients. J Gastrointest Cancer. 2010, 41:179-184.
5. Iconomou G, Iconomou AV, Argyriou AA, et al.: Emotional distress in cancer patients at the beginning of chemotherapy and its relation to quality of life. J BUON. 2008, 13:217-222. (Pubitemid 351836704)
6. Palesh OG, Roscoe JA, Mustian KM, et al.: Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol. 2010, 28:292-298.
7. Savard J, Villa J, Ivers H, Simard S, Morin CM: Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. J Clin Oncol. 2009, 27:5233-5239.
8. Beesley VL, Price MA, Butow PN, et al. (2011) Physical activity in women with ovarian cancer and its association with decreased distress and improved quality of life. Psychooncology (in press).
9. Stephenson LE, Bebb DG, Reimer RA, Culos-Reed SN: Physical activity and diet behaviour in colorectal cancer patients receiving chemotherapy: Associations with quality of life. BMC Gastroenterol. 2009, 9:60.
10. Beck SL, Berger AM, Barsevick AM, et al.: Sleep quality after initial chemotherapy for breast cancer. Support Care Cancer. 2010, 18:679-689.
11. Berger AM, Grem JL, Visovsky C, Marunda HA, Yurkovich JM: Fatigue and other variables during adjuvant chemotherapy for colon and rectal cancer. Oncol Nurs Forum. 2010, 37:E359-369.
12. Berger AM, Wielgus K, Hertzog M, Fischer P, Farr L (2010) Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy. Support Care Cancer 18 (1):105-114
13. Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH: Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. Journal of Clinical Oncology. 1998, 16:1689-1696. (Pubitemid 28234711)
14. Redeker NS, Lev EL, Ruggiero J: Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Scholarly Inquiry for Nursing Practice. 2000, 14:275-290; discussion 291-278
15. Mormont MC, Waterhouse J: Contribution of the rest-activity circadian rhythm to quality of life in cancer patients. Chronobiology International. 2002, 19:313-323. (Pubitemid 34310835)
16. Munir F, Yarker J, McDermott H: Employment and the common cancers: Correlates of work ability during or following cancer treatment. Occup Med (Lond). 2009, 59:381-389.
17. Curt GA, Breitbart W, Cella D, et al.: Impact of cancer-related fatigue on the lives of patients: New findings from the Fatigue Coalition. Oncologist. 2000, 5:353-360.
18. Tiedtke C, de Rijk A, Dierckx de Casterle B, Christiaens MR, Donceel P: Experiences and concerns about 'returning to work' for women breast cancer survivors: A literature review. Psychooncology. 2010, 19:677-683.
19. Gupta D, Lis CG, Grutsch JF: The relationship between cancerrelated fatigue and patient satisfaction with quality of life in cancer. J Pain Symptom Manage. 2007, 34:40-47. (Pubitemid 46963532)
20. Poulson MJ: Not just tired. J Clin Oncol. 2001, 19:4180-4181.
21. Savard J, Liu L, Natarajan L, et al.: Breast cancer patients have progressively impaired sleep-wake activity rhythms during chemotherapy. Sleep. 2009, 32:1155-1160.
22. Liu L, Fiorentino L, Natarajan L, et al.: Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy. Psychooncology. 2009, 18:187-194.
23. Berger AM, Higginbotham P: Correlates of fatigue during and following adjuvant breast cancer chemotherapy: A pilot study. Oncology Nursing Forum. 2000, 27:1443-1448.
24. de Jong N, Kester AD, Schouten HC, Abu-Saad HH, Courtens AM: Course of fatigue between two cycles of adjuvant chemotherapy in breast cancer patients. Cancer Nurs. 2006, 29:467-477. (Pubitemid 44900838)
25. Jacobsen PB, Hann DM, Azzarello LM, et al.: Fatigue in women receiving adjuvant chemotherapy for breast cancer: Characteristics, course, and correlates. Journal of Pain and Symptom Management. 1999, 18:233-242. (Pubitemid 29469701)
26. Ancoli-Israel S, Liu L, Marler MR, et al.: Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer. 2006, 14:201-209. (Pubitemid 43247923)
27. Berger AM, Farr L: The influence of daytime inactivity and nighttime restlessness on cancer-related fatigue. Oncology Nursing Forum. 1999, 26:1663-1671.
28. Donovan KA, Jacobsen PB: Fatigue, depression, and insomnia: Evidence for a symptom cluster in cancer. Semin Oncol Nurs. 2007, 23:127-135.
29. Stevinson C, Steed H, Faught W, et al.: Physical activity in ovarian cancer survivors: Associations with fatigue, sleep, and psychosocial functioning. Int J Gynecol Cancer. 2009, 19:73-78.
30. Servaes P, Verhagen CA, Bleijenberg G: Relations between fatigue, neuropsychological functioning, and physical activity after treatment for breast carcinoma: Daily self-report and objective behavior. Cancer. 2002, 95:2017-2026. (Pubitemid 35222183)
31. Roscoe JA, Morrow GR, Hickok JT, et al.: Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Supportive Care in Cancer. 2002, 10:329-336. (Pubitemid 36056288)
32. Palesh OG, Collie K, Batiuchok D, et al.: A longitudinal study of depression, pain, and stress as predictors of sleep disturbance among women with metastatic breast cancer. Biol Psychol. 2007, 75:37-44. (Pubitemid 46415652)
33. Badr H, Basen-Engquist K, Carmack Taylor CL, De Moor C: Mood states associated with transitory physical symptoms among breast and ovarian cancer survivors. J Behav Med. 2006, 29:461-475. (Pubitemid 44370966)
34. Holzner B, Kemmler G, Meraner V, et al.: Fatigue in ovarian carcinoma patients: A neglected issue? Cancer. 2003, 97:1564-1572. (Pubitemid 36297787)
35. Bodurka-Bevers D, Basen-Engquist K, Carmack CL, et al.: Depression, anxiety, and quality of life in patients with epithelial ovarian cancer. Gynecologic Oncology. 2000, 78:302-308.
36. Fox SW, Lyon D: Symptom clusters and quality of life in survivors of ovarian cancer. Cancer Nurs. 2007, 30:354-361. (Pubitemid 47417664)
37. Morgan RJ, Alvarez RD, Armstrong DK, et al.: NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer. Retrieved Sept. 23, 2009 from http://www.nccn.org/professionals/physician-gls/PDF/ovarian.pdf
38. Webster JB, Kripke DF, Messin S, Mullaney DJ, Wyborney G: An activity-based sleep monitor system for ambulatory use. Sleep. 1982, 5:389-399. (Pubitemid 13169662)
39. Patterson SM, Krantz DS, Montgomery LC, et al.: Automated physical activity monitoring: Validation and comparison with physiological and self-report measures. Psychophysiology. 1993, 30:296-305. (Pubitemid 23108340)
40. Sugimoto A, Hara Y, Findley TW, Yonemoto K: A useful method for measuring daily physical activity by a threedirection monitor. Scandanavian Journal of Rehabilitation Medicine. 1997, 29:37-42.
41. Berger AM, Wielgus KK, Young-McCaughan S, et al.: Methodological challenges when using actigraphy in research. Journal of Pain and Symptom Management. 2008, 36:191-199.
42. Rich T, Innominato PF, Boerner J, et al.: Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer. Clinical Cancer Research. 2005, 11:1757-1764. (Pubitemid 40471837)
43. Mormont MC, Langouet AM, Claustrat B, et al.: Marker rhythms of circadian system function: A study of patients with metastatic colorectal cancer and good performance status. Chronobiology International. 2002, 19:141-155. (Pubitemid 34310824)
44. Wainer H: Piecewise regression: A simplified procedure. British Journal of Mathematical and Statistical Psychology. 1971, 24:83-92.
45. McGee VE, Carleton WT: Piecewise regression. Journal of the American Statistical Association. 1970, 65:1109-1124.
46. Rumble ME, Keefe FJ, Edinger JD, et al.: Contribution of cancer symptoms, dysfunctional sleep related thoughts, and sleep inhibitory behaviors to the insomnia process in breast cancer survivors: A daily process analysis. Sleep. 2010, 33:1501-1509.
47. Payne J, Piper B, Rabinowitz I, Zimmerman B: Biomarkers, fatigue, sleep, and depressive symptoms in women with breast cancer: A pilot study. Oncol Nurs Forum. 2006, 33:775-783.
48. Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR: Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. J Clin Oncol. 2008, 26:971-982. (Pubitemid 351409339)